Fundz

Tc Xpress, Inc. reported raising $10 Million in an initial SEC Form D filing, from an offering of $15 Million

PRIVATEOct 01, 2018$10M of $15M raised

Amount Raised

$10 Million

$10 Million sold, per SEC Form D (first sale Oct 1, 2018)

Round Type

Venture

PittsburghOther

Quick answer

BlueSphere Bio, Inc. raised $10 Million in a funding round, dated October 1, 2018. BlueSphere Bio, Inc. is based in Pittsburgh, Pennsylvania, United States.

How much did BlueSphere Bio, Inc. raise?
BlueSphere Bio, Inc. raised $10 Million in a funding round on October 1, 2018.
What does BlueSphere Bio, Inc. do?
BlueSphere Bio is a novel TCXpress technology to unlock the potential of personalized T-cell therapy for the treatment of cancer .
Where is BlueSphere Bio, Inc. based and how big is it?
BlueSphere Bio, Inc. is based in Pittsburgh, Pennsylvania, United States.

Source: Fundz verified event record.

Who to call at BlueSphere Bio, Inc., and when

A new round usually means BlueSphere Bio, Inc. is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day BlueSphere Bio, Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at BlueSphere Bio, Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at BlueSphere Bio, Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

BlueSphere Bio, Inc.

Location

350 TECHNOLOGY DRIVE, SUITE 510

Pittsburgh, Pennsylvania, United States

About

BlueSphere Bio is a novel TCXpress technology to unlock the potential of personalized T-cell therapy for the treatment of cancer .

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment BlueSphere Bio, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for BlueSphere Bio, Inc.'s next move

See what Strategic adds

BlueSphere Bio, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.